Newsroom

Filtrer par
TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More

The videos and photos of the Conference “L’homme cérébral” that took place on March 30th, 2019 in Monaco are online

Learn More
european-business-trb-chemedica-interview

Read the European Business magazine interviews of Alessandro di Napoli

Learn More

Presentation of DISSCO results at the upcoming WCO-IOF-ESCEO congress in Paris

Learn More

The 125th International Congress of the French society of Ophthalmology, May 11 to 14, 2019, Paris (past event)

Learn More
Danny Webber football and Sports medecin with TRB Chemedica

Hyaluronic acid injections help to prolong sports careers for football players

Learn More